Omidubicel Increases Availability of Allogeneic Stem Cell Transplant
Chenyu Lin, MD, discusses the significance of a 10-year follow up of a study of patients who underwent allogeneic stem cell transplant with the novel cell therapy omidubicel.
Long-Term Follow Up Shows Potential of Omidubicel in Hematologic Malignancies
Chenyu Lin, MD, discusses the results of a 10-year follow up of patients who underwent allogenic stem cell therapy with the novel cell therapy omidubicel.